CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-27 | Gagnon Robert E. Chief Financial Officer | Grant or award | +62,500 | 213,500 | ||
| 2020-03-27 | Paterson Dan President and COO | Grant or award | +75,000 | 98,286 | ||
| 2020-03-27 | Stuglik Brian M Chief Executive Officer | Grant or award | +100,000 | 371,000 | ||
| 2020-03-06 | Ridgeback Capital Investments L.P. 10% owner | Conversion | +5,515,151 | 10,068,243 | ||
| 2020-03-06 | Ridgeback Capital Investments L.P. 10% owner | Conversion · 5% Convertible Senior Second Lien Notes due 2048 | −0 | |||
| 2019-12-13 | Gagnon Robert E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2019-12-13 | Gagnon Robert E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2019-12-13 | Paterson Dan President and COO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-12-13 | Paterson Dan President and COO | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2019-12-13 | Stuglik Brian M Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-07-29 | Stuglik Brian M Chief Executive Officer | Grant or award | +270,000 | 270,000 | ||
| 2019-07-29 | Stuglik Brian M Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2019-06-21 | Paterson Dan President and COO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2019-06-21 | Stuglik Brian M Director | Grant or award · Stock Option (Right to Buy) | +42,397 | 42,397 | ||
| 2019-06-21 | Stuglik Brian M Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 92,397 | ||
| 2019-06-21 | Consylman Gina Director | Grant or award · Stock Option (Right to Buy) | +5,137 | 5,137 | ||
| 2019-06-21 | Gagnon Robert E. Chief Financial Officer | Grant or award | +100,000 | 151,000 | ||
| 2019-06-21 | Gagnon Robert E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2019-06-21 | Wendel Bruce Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-06-21 | Lawton Alison Frances Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 18 of 23 · 448 trades